Literature DB >> 34255614

Exit from Brain Device Research: A Modified Grounded Theory Study of Researcher Obligations and Participant Experiences.

Lauren R Sankary1, Megan Zelinsky1, Andre Machado2, Taylor Rush2, Alexandra White3, Paul J Ford1.   

Abstract

As clinical trials end, little is understood about how participants exiting from clinical trials approach decisions related to the removal or post-trial use of investigational brain implants, such as deep brain stimulation (DBS) devices. This empirical bioethics study examines how research participants experience the process of exit from research at the end of clinical trials of implanted neural devices. Using a modified grounded theory study design, we conducted semi-structured, in-depth interviews with 16 former research participants from clinical trials of DBS and responsive neurostimulation (RNS). Open-ended questions elicited motivations for joining the trial, understanding of study procedures at the time of initial informed consent, the process of exiting from research, and decisions about device removal or post-trial device use. Thematic analysis identified categories related to: limited preparedness for the end of research participation, straightforwardness of decisions to explant or keep the device, reconciling with the end of research participation, reconciling post-trial expectations, and achieving a sense of closure after exit from research. A preliminary theoretical model describes contextual factors influencing the process and experience of exit from research. Experiences of clinical trial participants should guide research practices to enhance the ethical design and conduct of clinical trials in DBS and other brain devices.

Entities:  

Keywords:  Deep brain stimulation; informed consent; neuroethics; post-trial obligations; research ethics

Year:  2021        PMID: 34255614     DOI: 10.1080/21507740.2021.1938293

Source DB:  PubMed          Journal:  AJOB Neurosci        ISSN: 2150-7759


  1 in total

1.  Asking questions that matter - Question prompt lists as tools for improving the consent process for neurotechnology clinical trials.

Authors:  Andreas Schönau; Sara Goering; Erika Versalovic; Natalia Montes; Tim Brown; Ishan Dasgupta; Eran Klein
Journal:  Front Hum Neurosci       Date:  2022-07-29       Impact factor: 3.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.